Literature DB >> 18465796

ATP and fructose-2,6-bisphosphate regulate skeletal muscle 6-phosphofructo-1-kinase by altering its quaternary structure.

Patricia Zancan1, Monica M Marinho-Carvalho, Joana Faber-Barata, João M M Dellias, Mauro Sola-Penna.   

Abstract

Recently, it has been demonstrated that fructose-2,6-bisphosphate (F2,6BP) protects skeletal muscle 6-phosphofructo-1-kinase (PFK) from thermal inactivation (50 degrees C) and against the deleterious effects of guanidinium hydrochloride (GdmCl). On the other hand, ATP, when added at its inhibitory concentrations, that is, >1 mM, enhanced either the thermal- or GdmCl-induced inactivation of PFK. Moreover, we concluded that these phenomena were probably due to the stabilization of PFK tetrameric structure by F2,6BP, and the dissociation of this structure into dimers induced by ATP. Aimed at elucidating the effects of F2,6BP and ATP on PFK at the structural and functional levels, the present work correlates the effects of these metabolites on the equilibrium between PFK dimers and tetramers to the regulation promoted on the enzyme catalytic activity. We show that ATP present a dual effect on PFK structure, favoring the formation of tetramer at stimulatory concentrations (up to 1 mM), and dissociating tetramers into dimers at inhibitory concentrations (>1 mM). Furthermore, F2,6BP counteracted this later ATP effect at either the structural or catalytic levels. Additionally, the effects of both F2,6BP or ATP on the equilibrium between PFK tetramers and dimers and on the enzyme activity presented a striking parallelism. Therefore, we concluded that modulation of PFK activity by ATP and F2,6BP is due to the effects of these ligands on PFK quaternary structure, altering the oligomeric equilibrium between PFK tetramers and dimers. (c) 2008 IUBMB

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465796     DOI: 10.1002/iub.58

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  12 in total

1.  Glucuronoxylomannan from Cryptococcus neoformans down-regulates the enzyme 6-phosphofructo-1-kinase of macrophages.

Authors:  Juliana Grechi; Monica Marinho-Carvalho; Patricia Zancan; Leonardo Paes Cinelli; Andre M O Gomes; Marcio L Rodrigues; Leonardo Nimrichter; Mauro Sola-Penna
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

Review 2.  Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.

Authors:  Brandon C Jones; Paula R Pohlmann; Robert Clarke; Surojeet Sengupta
Journal:  Cancer Metastasis Rev       Date:  2022-04-14       Impact factor: 9.237

3.  Crystallization and preliminary crystallographic analysis of human muscle phosphofructokinase, the main regulator of glycolysis.

Authors:  Marco Kloos; Antje Brüser; Jürgen Kirchberger; Torsten Schöneberg; Norbert Sträter
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-25       Impact factor: 1.056

4.  Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations.

Authors:  Bradley A Webb; Farhad Forouhar; Fu-En Szu; Jayaraman Seetharaman; Liang Tong; Diane L Barber
Journal:  Nature       Date:  2015-05-18       Impact factor: 49.962

Review 5.  The sarcomeric M-region: a molecular command center for diverse cellular processes.

Authors:  Li-Yen R Hu; Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

Review 6.  Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof.

Authors:  Tanya McDonald; Michelle Puchowicz; Karin Borges
Journal:  Front Cell Neurosci       Date:  2018-08-31       Impact factor: 5.505

7.  Functional Roles of Metabolic Intermediates in Regulating the Human Mitochondrial NAD(P)+-Dependent Malic Enzyme.

Authors:  Ju-Yi Hsieh; Wan-Ting Shih; Yu-Hsuan Kuo; Guang-Yaw Liu; Hui-Chih Hung
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

Review 8.  Glycolysis in energy metabolism during seizures.

Authors:  Heng Yang; Jiongxing Wu; Ren Guo; Yufen Peng; Wen Zheng; Ding Liu; Zhi Song
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

9.  Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma.

Authors:  Raquel G Coelho; Isadora C Calaça; Deborah M Celestrini; Ana Helena P Correia-Carneiro; Mauricio M Costa; Patricia Zancan; Mauro Sola-Penna
Journal:  Oncotarget       Date:  2015-10-06

10.  In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.

Authors:  Sainan Li; Liwei Wu; Jiao Feng; Jingjing Li; Tong Liu; Rong Zhang; Shizan Xu; Keran Cheng; Yuqing Zhou; Shunfeng Zhou; Rui Kong; Kan Chen; Fan Wang; Yujing Xia; Jie Lu; Yingqun Zhou; Weiqi Dai; Chuanyong Guo
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.